
Janus Genomics helps biomedical companies extract insights from combined proprietary datasets without exposing the underlying data. The company provides a platform and AI tools that enable joint training of algorithms across diverse biomedical datasets while preserving data privacy. Its solution targets biomedical and life-science organizations and supports monetization of data assets without sharing raw data. Janus Genomics is delivered as a B2B SaaS platform that emphasizes privacy-preserving training techniques and integrations with customers’ existing data environments. The company has received support from Entrepreneurs First, the Max Planck Institute, and the University of Regensburg.

Janus Genomics helps biomedical companies extract insights from combined proprietary datasets without exposing the underlying data. The company provides a platform and AI tools that enable joint training of algorithms across diverse biomedical datasets while preserving data privacy. Its solution targets biomedical and life-science organizations and supports monetization of data assets without sharing raw data. Janus Genomics is delivered as a B2B SaaS platform that emphasizes privacy-preserving training techniques and integrations with customers’ existing data environments. The company has received support from Entrepreneurs First, the Max Planck Institute, and the University of Regensburg.
What they built: Privacy-preserving AI platform for collaborative training on biomedical/genomic datasets
Customers: Biotech, pharmaceutical companies, and research institutions
Location: Berlin, Germany
Founders: Mohammad Sadeh; Robin Röhm
Status / stage: Listed as closed / no longer active
Privacy-preserving AI and collaborative model training for biomedical/genomic data
2018
Biotechnology
116,685 USD
“Backed by Entrepreneurs First”